UCB |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.6 EUR | +0.81% |
|
+2.09% | +57.86% |
| Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
| Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 25.27B | ||||||
| 86.85B | ||||||
| 40.16B | ||||||
| 31.28B | ||||||
| 15.33B | ||||||
| 11.96B |
- Stock Market
- Equities
- UCB Stock
- Charts UCB
- Sector Chart
